Lipedema Clinical Trials

Find Lipedema Clinical Trials Near You

Validity and Reliability Study of the Turkish Version of the Duke Activity Status Index in Patients With Lipedema

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study aims to evaluate the validity and reliability of the Turkish version of the Duke Activity Status Index (DASI) in women with lipedema. DASI is a 12-item questionnaire designed to assess functional capacity based on activities of daily living. The study will examine the test-retest reliability and internal consistency of the Turkish DASI and investigate its validity by examining its relationships with functional exercise capacity, lower extremity function, and health-related quality of life. The findings are expected to determine whether the Turkish DASI is a valid and reliable tool for assessing functional capacity in women with lipedema.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Female sex. Aged 18 to \<65 years. Diagnosis of lipedema. No participation in a physiotherapy program within the previous 3 months. No history of liposuction surgery. Not currently following a weight-loss diet. No change in body weight greater than 10% within the previous 6 months. Willing to participate in the study and able to provide informed consent.

Locations
Other Locations
Turkey
Bezmialem Vakif University
RECRUITING
Istanbul
Contact Information
Primary
Merve SEVİNC GUNDUZ, MSc
mrvsevinccc@gmail.com
+90 5312991841
Time Frame
Start Date: 2026-08-25
Estimated Completion Date: 2026-10-30
Participants
Target number of participants: 34
Treatments
Women With Lipedema
Women diagnosed with lipedema who meet the eligibility criteria will be included in this study. Participants will undergo assessments of functional capacity, lower extremity function, and health-related quality of life using the Duke Activity Status Index (DASI), Six-Minute Walk Test (6MWT), Lower Extremity Functional Scale (LEFS), and 36-Item Short Form Health Survey (SF-36). The DASI will be administered again after 7 days to assess test-retest reliability.
Related Therapeutic Areas
Sponsors
Leads: Istanbul University - Cerrahpasa

This content was sourced from clinicaltrials.gov